Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Debt / NOTE 0.125%12/1
-
Market price (% of par)
-
98.06%
-
Total 13F principal
-
$44,651,000
-
Principal change
-
+$1,740,000
-
Total reported market value
-
$43,150,120
-
Number of holders
-
16
-
Value change
-
+$1,968,865
-
Number of buys
-
3
-
Number of sells
-
7
Institutional Holders of IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 as of Q2 2024
As of 30 Jun 2024,
IONIS PHARMACEUTICALS INC - NOTE 0.125%12/1 was held by
16 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$44,651,000
in principal (par value) of the bond.
The largest 10 bondholders included
Sonora Investment Management Group, LLC, Fort Baker Capital Management LP, PALISADE CAPITAL MANAGEMENT, LP, Kohlberg Kravis Roberts & Co. L.P., Penn Mutual Asset Management, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, HighTower Advisors, LLC, MACQUARIE GROUP LTD, JPMORGAN CHASE & CO, and SCHRODER INVESTMENT MANAGEMENT GROUP.
This page lists
16
institutional bondholders reporting positions
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.